C. Ferrarese et al., Decreased platelet glutamate uptake and genetic risk factors in patients with Parkinson's disease, NEUROL SCI, 22(1), 2001, pp. 65-66
Genetic risk factors seem to play a role in sporadic Parkinson's disease (P
D), maybe triggering oxidative stress and excitotoxicity within substantia
nigra. However, genetic factors act at systemic level: reduced activity of
mitochondrial enzymes and decreased glutamate uptake have been shown in pla
telets from PD patients. In this study we investigated glutamate uptake in
platelets from 38 sporadic PD patients, 13 patients with parkinsonian syndr
omes and 28 controls and assessed polymorphisms of alpha -synuclein and Apo
E genes. A 48% reduction of glutamate uptake (p<0.0001) was observed in PD
patients which, with respect to control groups, correlated with the disease
severity (r = -0.44, p < 0.05). Genetic studies of this population did not
show differences between PD and controls, nor correlations with platelet g
lutamate uptake.